Evidence-based interventions in the early phase of schizophrenic disorders

被引:1
作者
Dold, Josua [1 ]
Droews, Lisa [1 ]
Vauth, Roland [1 ]
机构
[1] Univ Basel, Univ Psychiat Kliniken, Gesundheitszentrum Psychiat Kornhausgasse, Basel, Switzerland
来源
ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE | 2017年 / 65卷 / 02期
关键词
first episode schizophrenia; cognitive behaviour therapy; relapse prevention; recovery; personalized medicine; psychopharmacotherapy; COGNITIVE REMEDIATION; SELF-STIGMA; RECOVERY; PEOPLE; FACTS; MODEL; ANTIPSYCHOTICS; METAANALYSIS; PSYCHOSIS; SYMPTOMS;
D O I
10.1024/1661-4747/a000310
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
By addressing the early phase of first episode psychosis, we focus on the "critical period" in the development of schizophrenia. Treatment success during this vulnerable period of development of schizophrenia sets the course for the future long-term development of the illness (partial remission, role functioning). This indicates the need not only for an optimization of the cost-benefit-ratio of antipsychotic treatment with more recent atypicals and newer formulations, but also the need to supplement disorder-specific, problem-specific and phase-specific cognitive-behavioral interventions within a more individualized approach which focuses on developmental tasks and the more evaluative dimension of self-concept. Preventing neurotoxic relapse as well as partial remission in schizophrenia and enhancing role functioning in education and work (i. e. social integration) are the most important goals of early interventions in this early phase of the course of schizophrenia.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 41 条
  • [1] Social cognition and its neural correlates in schizophrenia and autism
    Abdi, Z
    Sharma, T
    [J]. CNS SPECTRUMS, 2004, 9 (05) : 335 - 343
  • [2] The experience of recovery from schizophrenia: towards an empirically validated stage model
    Andresen, R
    Oades, L
    Caputi, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 (05) : 586 - 594
  • [3] [Anonymous], SYSTEMATIC TREATMENT
  • [4] [Anonymous], 2011, PSYCHOPHARMACOLOGY I
  • [5] Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication
    Beck, Eva-Marina
    Cavelti, Marialuisa
    Kvrgic, Sara
    Kleim, Birgit
    Vauth, Roland
    [J]. SCHIZOPHRENIA RESEARCH, 2011, 132 (01) : 42 - 49
  • [6] Assessing recovery from schizophrenia as an individual process. A review of self-report instruments
    Cavelti, M.
    Kvrgic, S.
    Beck, E. -M.
    Kossowsky, J.
    Vauth, R.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27 (01) : 19 - 32
  • [7] Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders
    Cavelti, Marialuisa
    Kvrgic, Sara
    Beck, Eva-Marina
    Ruesch, Nicolas
    Vauth, Roland
    [J]. COMPREHENSIVE PSYCHIATRY, 2012, 53 (05) : 468 - 479
  • [8] The burden of depressive symptoms in the long-term treatment of patients with schizophrenia
    Conley, Robert R.
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas E.
    Kinon, Bruce J.
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 186 - 197
  • [9] Examining a progressive model of self-stigma and its impact on people with serious mental illness
    Corrigan, Patrick W.
    Rafacz, Jennifer
    Ruesch, Nicolas
    [J]. PSYCHIATRY RESEARCH, 2011, 189 (03) : 339 - 343
  • [10] Drake Robert E, 2009, Dialogues Clin Neurosci, V11, P455